This Billion Operational Beat Reshapes AbbVie Thesis for Investors
AbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesAbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
Netflix trades near its 52-week low as operating strength clashes with subscriber-growth concerns. A stronger FY26 ca...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
As AI hype accelerates, Clarivate (CLVT) quietly leans on its defensible data assets to reduce debt and position for ...
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
As AI stocks grab headlines, Netflix quietly presents a compelling valuation case. This guide weighs the factors behi...
SSR Mining stock surged again as gold prices nudged higher and a strategic asset sale hinted at improved cash flow. T...
Rents have moved in a new direction, but not every landlord should raise them right away. This guide helps you decide...
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...
Flotek's 2025 earnings outlook hinges on energy demand, cost control, and segment mix. This guide breaks down what to...
Steris (STE) offers a steady earnings narrative in a healthcare environment shaped by infection control needs. This a...
A smaller social media platform is trading under $30 while delivering double-digit revenue growth and robust cash flo...